Please use this identifier to cite or link to this item: https://hdl.handle.net/1822/64309

TitleCombining neuroprotective agents: effect of riluzole and magnesium in a rat model of thoracic spinal cord injury
Author(s)Vasconcelos, Natália L.
Gomes, Eduardo Domingos Correia
Oliveira, Maria Eduarda Moreira Pinheiro Santos
Silva, Carlos J. R.
Lima, Rui
Sousa, Nuno
Salgado, A. J.
Silva, Nuno André Martins
KeywordsAnimals
Drug therapy, combination
Female
Magnesium
Neuroprotective agents
Rats
Rats, wistar
Riluzole
Spinal cord Injuries
Excitotoxicity
Ionic imbalances
Neuroprotection
Spinal cord injury
Issue date2016
PublisherElsevier
JournalThe Spine Journal
Abstract(s)BACKGROUND CONTEXT: Damage to the spinal cord can result in irreversible impairments or complete loss of motor, sensory, and autonomic functions. Riluzole and magnesium have been widely investigated as neuroprotective agents in animal models of spinal cord injury. As these drugs protect the injured spinal cord through different mechanisms, we aimed to investigate if their neuroprotective efficacy could be cumulative. PURPOSE: This study aimed to investigate the neuroprotective efficacy of combined administration of riluzole and magnesium chloride in a contusive model of thoracic spinal cord injury. STUDY DESIGN: An in vivo experiment was set using female Wistar Han rats that underwent a thoracic spinal cord contusion (T8) using a weight drop method. An hour after injury, animals were randomly distributed to receive (1) saline, (2) riluzole (2.50 mg/kg), (3) magnesium chloride (24.18 mg/kg) in a polyethylene glycol formulation, or (4) a combined treatment (riluzole and magnesium). Subsequent treatments were given in four intraperitoneal injections (spaced 12 hours apart). METHODS: The Basso, Beattie, and Bresnahan locomotor rating scale, an activity box test, and a swimming test were used to evaluate behavioral recovery over a 4-week period. Histologic analysis of the spinal cords was performed to measure the extent and volume of the lesion, axonal preservation, serotonergic and glutamatergic fiber sparing, motor neuron survival, and inflammation. RESULTS: Our results show that only the riluzole treatment significantly improved behavioral recovery up to 4 weeks after injury when compared with saline controls (6.2±1.8), with animals achieving weight-supported stepping (9.1±1.2). Riluzole also promoted tissue sparing with significant differences achieved from 200 to 600 m (caudally to the lesion epicenter), and reduced lesion volume, with animals presenting a significantly smaller lesion (3.23±0.26 mm3 ) when compared with the saline-treated group (4.74±0.80 mm3 ), representing a 32% decrease in lesion volume. Riluzole treatment induced significant axonal preservation, as well as serotonergic fiber sparing, caudally to the injury epicenter. CONCLUSIONS: Our results suggest that the combined treatment, although simultaneously targeting two excitotoxic-related mechanisms, did not further improve behavioral and histologic outcome when compared with riluzole given alone.
TypeArticle
URIhttps://hdl.handle.net/1822/64309
e-ISBN1878-1632
DOI10.1016/j.spinee.2016.04.013
ISSN1529-9430
Publisher versionhttps://www.thespinejournalonline.com/article/S1529-9430(16)30041-9/abstract
Peer-Reviewedyes
AccessRestricted access (UMinho)
Appears in Collections:ICVS - Artigos em revistas internacionais / Papers in international journals

Files in This Item:
File Description SizeFormat 
Vasconcelos-2016-Combining-neuroprotective-agents-ef.pdf
  Restricted access
2,37 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID